ArticleTargeted oncology2014

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.

Laura M Alwan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.